St. Jude Medical (STJ) announced it has acquired Nanostim, Inc., a California-based early-stage medical device company focused on leadless pacemaker technology, for $123.5 million. The startup could stand to gain up to an additional $65 million if it meets certain milestones. This deal culminates a partnership that began on May 3, 2011, when STJ decided […]
A medical device company developing an earlier intervention for cartilage damage and osteoarthritis is raising a $14.2 million round. Biomimedica Inc. has already secured $11.9 million from 10 investors, according to a U.S. Securities and Exchange Commission filing. CEO Jeff Roberts did not return a call for comment. The company is developing synthetic cartilage for […]
Veradigm examines key clinical trends, comorbidity profiles, and treatment trends across adolescence, reproductive years, and peri-/post-menopause. Download it today!
Life science investment firm Emergent Medical Partners LP has raised nearly $70 million in a pooled investment fund over the past four-and-a-half years, according to two U.S. Securities and Exchange Commission filings on Thursday (here and here). The Portolo Valley, California firm led by medical device pioneer Dr. Thomas Fogarty (one of MedCity News readers’ […]
Ardian is developing a catheter system that disrupts the sympathetic nerves in the kidneys, which will in turn reduce blood pressure. Clinical trials are expected next week.